JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.54% |
| 2 | Financials | 14.6% |
| 3 | Technology | 12.1% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GHDX
4351
DELISTED
Genomic Health, Inc.
GHDX
| $33K | ﹤0.01% |
1,049
+80
| +8% | +$2.52K |
2014 Q4
11 quarters
|
|
4352
Invesco Oil & Gas Services ETF
PXJ
$126M
| $32K | ﹤0.01% |
649
| – | – |
2015 Q4
7 quarters
|
|
4353
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $32K | ﹤0.01% |
2,215
+225
| +11% | +$2.49K |
2016 Q4
3 quarters
|
|
|
MRTX
4354
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $32K | ﹤0.01% |
+2,777
| New | +$16.1K |
2017 Q3
0 quarters
|
|
|
GBL
4355
DELISTED
GAMCO Investors, Inc.
GBL
| $32K | ﹤0.01% |
1,074
+162
| +18% | +$4.81K |
2016 Q4
3 quarters
|
|
|
AFAM
4356
DELISTED
Almost Family Inc
AFAM
| $32K | ﹤0.01% |
595
+86
| +17% | +$4.38K |
2016 Q4
3 quarters
|
|
4357
VanEck Digital Native Economy ETF
GENZ
$16.5M
| $31K | ﹤0.01% |
727
-411
| -36% | -$16.7K |
2017 Q1
2 quarters
|
|
4358
First Trust Multi Cap Value AlphaDEX Fund
FAB
$161M
| $31K | ﹤0.01% |
578
| – | – |
2013 Q2
17 quarters
|
|
4359
MediciNova
MNOV
$71.9M
| $31K | ﹤0.01% |
4,876
+4,800
| +6,316% | +$25.5K |
2016 Q1
6 quarters
|
|
4360
Materialise
MTLS
$470M
| $31K | ﹤0.01% |
2,254
-3,605
| -62% | -$48.8K |
2017 Q1
2 quarters
|
|
4361
PAR Technology
PAR
$724M
| $31K | ﹤0.01% |
3,124
+3,024
| +3,024% | +$29.1K |
2017 Q2
1 quarter
|
|
4362
WisdomTree Europe SmallCap Dividend Fund
DFE
$161M
| $30K | ﹤0.01% |
440
-48
| -10% | -$3.22K |
2014 Q2
13 quarters
|
|
4363
First Trust S&P REIT Index Fund
FRI
$184M
| $30K | ﹤0.01% |
+1,291
| New | +$30.1K |
2017 Q3
0 quarters
|
|
4364
PLDT
PHI
$4.25B
| $30K | ﹤0.01% |
966
+136
| +16% | +$4.53K |
2013 Q2
17 quarters
|
|
4365
DELISTED
Alpine Immune Sciences Inc
ALPN
| $30K | ﹤0.01% |
2,600
+1,000
| +63% | +$9.35K |
2017 Q2
1 quarter
|
|
|
DFRG
4366
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $30K | ﹤0.01% |
2,043
+330
| +19% | +$4.78K |
2015 Q2
9 quarters
|
|
|
BSJI
4367
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
| $30K | ﹤0.01% |
1,200
| – | – |
2017 Q2
1 quarter
|
|
4368
Gabelli Equity Trust
GAB
$1.79B
| $29K | ﹤0.01% |
4,640
| – | – |
2015 Q4
7 quarters
|
|
4369
Ooma
OOMA
$553M
| $29K | ﹤0.01% |
+2,685
| New | +$23.7K |
2017 Q3
0 quarters
|
|
4370
Invesco Financial Preferred ETF
PGF
$610M
| $29K | ﹤0.01% |
1,518
-11,411
| -88% | -$217K |
2014 Q1
14 quarters
|
|
4371
NYLIM Hedge Multi-Strategy Tracker ETF
QAI
$997M
| $29K | ﹤0.01% |
970
| – | – |
2017 Q1
2 quarters
|
|
4372
Barings BDC
BBDC
$898M
| $28K | ﹤0.01% |
2,003
-11,279
| -85% | -$170K |
2015 Q4
7 quarters
|
|
4373
Great Elm Capital Corp
GECC
$69.7M
| $28K | ﹤0.01% |
+444
| New | +$28.7K |
2017 Q3
0 quarters
|
|
4374
DELISTED
Meridian Bioscience Inc
VIVO
| $28K | ﹤0.01% |
1,982
+280
| +16% | +$4K |
2015 Q3
8 quarters
|
|
|
DL
4375
DELISTED
China Distance Education Holdings Limited
DL
| $28K | ﹤0.01% |
4,121
+3,844
| +1,388% | +$28K |
2016 Q3
4 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 501 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 501 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.